The recurrence rate of stage IB lung cancer is around 30%.
Stage ⅠB lung cancer is still in early stage and the treatment rate is still relatively high. Most of the stage ⅠB lung cancers in clinical practice can be resected by radical surgery in time, and according to the condition of postoperative targeted radiotherapy and chemotherapy, the cure rate can reach more than 70%, and the three-year recurrence rate can be kept at around 30%, but it depends on the specific physical condition, treatment plan, and post-care.
Stage IB lung cancer can be effectively prolonged by actively adopting targeted consolidation treatment, which can reduce its recurrence rate, and regular review and timely targeted treatment once abnormalities are found.